Sign in to continue:

Friday, July 31st, 2026

Day: May 13, 2026

Enanta Pharmaceuticals Q2 2026 Financial Results and Management Discussion – 10-Q Report Highlights

Enanta Pharmaceuticals Q2 2026 Financial Report: Investor In...

HG Holdings, Inc. Q1 2026 Financial Report: Consolidated Statements, Earnings, and Market Analysis

HG Holdings, Inc. Q1 2026 Financial Report: Investor Analysi...

Avalo Therapeutics, Inc. Q1 2026 10-Q Report: Financial Statements, Results, and SEC Filings Overview

Avalo Therapeutics, Inc. Q1 2026 Financial Report: Key Highl...

Protalix BioTherapeutics, Inc. Q1 2026 Financial Results & SEC 10-Q Filing Overview

Protalix Biotherapeutics, Inc. Q1 2026 Financial Report - In...

Charlotte’s Web Holdings, Inc. Q1 2026 Financial Report: Revenue, Losses, and Business Overview

Charlotte's Web Holdings, Inc. Q1 2026 Financial Report - In...

Upstream Bio, Inc. 2026 Q1 Financials and Risk Factors – Nasdaq Global Select Market Filing

Upstream Bio, Inc. Q1 2026 Financial Report – Investor Analy...